BAILARD, INC. - JUNO THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 178 filers reported holding JUNO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.38 and the average weighting 1.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BAILARD, INC. ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$1,646,000
+83.5%
36,000
+80.0%
0.10%
+50.7%
Q3 2017$897,000
+85.3%
20,000
-8.3%
0.07%
+72.5%
Q1 2017$484,000–21,800–0.04%–
 Download
Other shareholders
JUNO THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
IFP Advisors, Inc 3,484$159,0000.01%
Omega Fund Management, LLC 0$00.00%
GLENMEDE TRUST CO NA 156$7,0000.00%
View complete list of JUNO THERAPEUTICS INC shareholders